RTI Surgical Reduces Guidance Due to Softer than Expected coflex Sales

RTI Surgical reported 3Q19 orthopedic revenue of USD $65.7 million, +10.7% vs. 3Q18.

RTI Surgical downgraded 2019 full-year guidance from a range of $325-$335 million to $305-$310 million
Sales of legacy spine products, such as the Fortilink interbody fusion device, slowed and were impacted by the loss of a key customer due to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us